Immunity to tumors 2 Flashcards

1
Q

What suffix is used for monoclonal antibodies

A

-mab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does rituximab target, how does it cause cell lysis

A

CD-20 (non-Hodgkin’s lymphoma), compliment fixation, antibody dependent cell mediated cytotoxicity, induction of apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Due to rituximab being a chimeric antibody what are precautions that must be taken prior to infusion

A

premedication, slowly titrate infusion, vigilant surveillance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What viral disease must be screened prior to first dose of rituximab, if present what is given as well

A

Hepatitis B, entecavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What drug is used for prophylaxis of tumor lysis syndrome due to rituximab

A

Allopurinol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are actions that should be done if there is a moderate infusion reaction, severe infusion reaction (anaphylaxis)

A

stop infusion, administer corticosteriods and H1/H2 blockers, restart infusion at slower rate/ administer hydration, epinephrine and bronchodilators, rechallenge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are antibody-drug conjugates comprised of

A

Antibody, linker, cytotoxic agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the linker do in antibody-drug conjugates

A

attaches the cytotoxic agent to the antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does anti-CTLA-4 do

A

Binds to CTLA-4 instead of CTLA-4 binding to B7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Ipilimumab

A

monoclonal antibody to CTLA-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are dermatological side effects to using Ipilimumab, how often does it happen

A

itcing and rash, 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How are dermatological side effects managed for Ipilimumab

A

oral antipruritics, grade 3/4 require topical and/or oral corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What gastrointestinal side effects to using Ipilimumab

A

diarrhea, abdominal pain, blood and mucous in stool, ileus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are gastrointesinal side effects managed for Ipilimumab

A

corticosteroids for proloned grade 2 (less than one week) or any grade 3/4, discontinue for grade 3/4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is grade 2, grade 3 in colitis and diarrhea

A

Colitis: grade 2- abdominal pain, mucus or blood in stool grade 3- severe abdominal pain
Diarrhea: grade 2- increase of 4-6 stools per day grade 3 increase of seven or more stools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is grade 4 and grade5 in colitis and diarrhea

A

life-threatening, death

17
Q

What are endocrine side effects in using Ipilimumab

A

fatigue, headache, abnormal thyroid test, hypotension

18
Q

How are endocrine side effects in using Ipilimumab managed

A

withhold treatment, treat hyper or hypothyroidism

19
Q

What are pulmonary side effects in using Ipilimumab

A

shortness of breath, inflammation of walls of aveoli (pneumonitis)

20
Q

How does PD-1/PD-L1 antagonists work

A

inhibit inreactions on T-cell and/or tumor cell

21
Q

T/F: Anti-PD-1 monoclonal antibodies inhibit interactions on tumor cells while Anti-PD-L1 inhibt interactions on T cells

A

False: Anti-PD-1 inhibt T-cell and Anti-PD-L1 inhibit interactions on tumor cells

22
Q

What are the PD-1 antibody medications

A

Nivolumab (Opdivo), Pembrolizumab (Keytruda)

23
Q

What are the PD-L1- antibody medications

A

Atezolizumab (Tecentriq), Avelumab (Bavencio), Durvalumab (Imfinzi)

24
Q

What are features of PD-1/PD-L1 antagonists

A

convienient dosing every 3-4 weeks, monotherapy or combination, no premedications required

25
T/F: Steroids should be avoided when using PD-1/PD-L1 antagonsits
True
26
How do bi-specific T cell (BITEs) engagers work, how are they taken
Combination of CD-19 single chain antibody connected to Cd-3 antibody via linker connecting T cells to B- cells, given as continous infusion for 28 days then 14 days off treatment
27
What are the adverse reactions to (BITEs)
cytokine release syndrome, neurotoxicity
28
What medication is a bi-specific T cell engager
Blinatumomab (blincyto)
29
What are some cytokine release syndrome side effecs
headache, high fever, hypotension, rash, fatigue, dyspnea
30
What are some cytokines released during cytokine release syndrome
IFN-gamma, IL-6, IL-2, IL-8, or IL-10, TNF-alpha
31
What drug is given with grade 3 or 4 cytokine release due to blinatumomab, what does it do
Tocolizumab (actemra), IL-6 receptor antagonist that causes a reduction in cytokine and acute phase reactant production
32
How often does neurtoxicty occur in BiTEs therapy, when do symptoms occur, what should be avoided
2 out of 3 patients, 8 weeks, refrain from driving
33
What are the premediacations for CAR-T therapy
Acetaminophen and Diphenhydramine
34
What are side effects of CAR-T therapy
Cytokine release syndrome, neurotoxicity, anaphylaxis,